Integer (ITGR) versus Its Competitors Head-To-Head Comparison

Integer (NYSE:ITGR – Get Free Report) is one of 511 public companies in the “Healthcare Equipment & Supplies” industry, but how does it compare to its rivals? We will compare Integer to related businesses based on the strength of its institutional ownership, valuation, analyst recommendations, risk, earnings, dividends and profitability.

Earnings & Valuation

This table compares Integer and its rivals revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Integer $1.83 billion $102.81 million 42.50
Integer Competitors $1.89 billion $136.85 million 5.73

Integer’s rivals have higher revenue and earnings than Integer. Integer is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.

Profitability

This table compares Integer and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Integer 5.68% 11.84% 5.98%
Integer Competitors -300.62% -179.55% -22.71%

Insider and Institutional Ownership

99.3% of Integer shares are owned by institutional investors. Comparatively, 40.5% of shares of all “Healthcare Equipment & Supplies” companies are owned by institutional investors. 1.1% of Integer shares are owned by company insiders. Comparatively, 14.9% of shares of all “Healthcare Equipment & Supplies” companies are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Risk and Volatility

Integer has a beta of 0.6, meaning that its stock price is 40% less volatile than the S&P 500. Comparatively, Integer’s rivals have a beta of 5.41, meaning that their average stock price is 441% more volatile than the S&P 500.

Analyst Recommendations

This is a summary of recent ratings for Integer and its rivals, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Integer 0 11 1 0 2.08
Integer Competitors 4309 10596 18377 837 2.46

Integer presently has a consensus price target of $113.67, indicating a potential downside of 10.25%. As a group, “Healthcare Equipment & Supplies” companies have a potential upside of 21.78%. Given Integer’s rivals stronger consensus rating and higher probable upside, analysts plainly believe Integer has less favorable growth aspects than its rivals.

Summary

Integer rivals beat Integer on 8 of the 13 factors compared.

Integer Company Profile

(Get Free Report)

Integer Holdings Corporation develops and manufactures medical-device components and provides outsourced manufacturing services for medical technology companies. Its products are used in devices for cardiac rhythm management, neuromodulation, cardiovascular care, and other medical applications. The company’s offerings include batteries, capacitors, leads, catheters, and precision components, as well as engineered assemblies and manufacturing support. Integer serves medical-device original equipment manufacturers around the world.

Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.